4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-21-034610
Chief Business Officer bought 2,500 shares at $9.08 ($22,708)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Desmarais William Chief Business Officer | 2021-08-27 | Purchase | +2,500 | $9.08 | $22,708 | 2,500 | D: show line 1 in the form |
| Open-market purchases · 2,500 sh · avg $9.08 · $22,708 | |||||||
Loading xslF345X03/doc4.xml…